Igyxos S.A. has completed a Series A fundraising
February 2019 — Igyxos S.A. has completed a US$8.4 million fundraising as part of a Series A funding led by Bpifrance through its FABS Fund, with participation from the Go Capital Amorçage II and Loire Valley Invest Funds and by the Emergence Innovation II. This will allow the founder Marie Christine Maurel and Professor René Frydman, joined by Pierre-Henry Longeray (ex Merck Serono) as CEO, to pursue the proof of concept in human clinical practice.
Based in Nouzilly, France, biotechnology startup Igyxos is developing a new treatment for female and male infertility that works by shifting hormonal imbalances with a new method using monoclonal antibodies.
Our role in the transaction
Oaklins’ team in France advised Igyxos on a "dual-track" project that allowed them to validate with the industry both scientific and therapeutic interest of its drug candidate based on the use of monoclonal antibodies to improve the treatment of female and male infertility.
Marie-Christine Maurel
CSO and Founder, Igyxos, S.A.
Talk to the deal team
Related deals
Nymann Kloak- & Miljøservice has been acquired by Serwent Group
Nymann Kloak- & Miljøservice has been acquired by Serwent Group. The acquisition expands Serwent’s footprint in Denmark while broadening its service offering and strengthening capacity across its existing platform. This transaction further supports Serwent’s ambition to become the leading Nordic operator in underground infrastructure maintenance.
Learn moreHeka Dental has joined forces with Impilo to anchor focused buy-and-build strategy
Heka Dental, a leading Danish designer and manufacturer of premium dental treatment units, has been acquired by the Swedish private equity firm Impilo. The acquisition establishes Heka Dental as a strategic platform for consolidation in the European dental equipment market. Impilo will execute a focused buy-and-build strategy to accelerate growth and expand its footprint across Europe.
Learn moreGP-Connect has joined forces with Transformation Capital to accelerate growth
Transformation Capital, a Netherlands-based investment firm, has joined forces with GP-Connect, a leading international secondment platform with specialized brands serving the hospitality, IT, skilled labor, technical services and dental sectors. As part of the transaction, GP-Connect welcomes Transformation Capital as its new shareholder to support the company’s next phase of growth, while the founders and existing shareholders will remain actively involved. The partnership will focus on executing a targeted buy-and-build strategy, expanding the business internationally and further strengthening GP-Connect’s portfolio.
Learn more